Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1979 1
1980 1
1981 1
1982 2
1987 1
1988 3
1992 3
1993 1
1994 1
1995 1
1997 6
1998 7
1999 2
2001 5
2002 3
2003 6
2004 4
2005 5
2006 2
2008 4
2009 1
2010 4
2011 5
2012 4
2013 7
2014 6
2015 5
2016 6
2017 5
2018 3
2019 5
2020 3
2021 5
2022 5
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

123 results

Results by year

Filters applied: . Clear all
Page 1
Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial.
Grothey A, Van Cutsem E, Sobrero A, Siena S, Falcone A, Ychou M, Humblet Y, Bouché O, Mineur L, Barone C, Adenis A, Tabernero J, Yoshino T, Lenz HJ, Goldberg RM, Sargent DJ, Cihon F, Cupit L, Wagner A, Laurent D; CORRECT Study Group. Grothey A, et al. Lancet. 2013 Jan 26;381(9863):303-12. doi: 10.1016/S0140-6736(12)61900-X. Epub 2012 Nov 22. Lancet. 2013. PMID: 23177514 Clinical Trial.
Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial.
Bennouna J, Sastre J, Arnold D, Österlund P, Greil R, Van Cutsem E, von Moos R, Viéitez JM, Bouché O, Borg C, Steffens CC, Alonso-Orduña V, Schlichting C, Reyes-Rivera I, Bendahmane B, André T, Kubicka S; ML18147 Study Investigators. Bennouna J, et al. Lancet Oncol. 2013 Jan;14(1):29-37. doi: 10.1016/S1470-2045(12)70477-1. Epub 2012 Nov 16. Lancet Oncol. 2013. PMID: 23168366 Clinical Trial.
Inhibitors of Angiogenesis.
Büning H, Hacker UT. Büning H, et al. Among authors: hacker ut. Adv Exp Med Biol. 2016;917:261-85. doi: 10.1007/978-3-319-32805-8_12. Adv Exp Med Biol. 2016. PMID: 27236560 Review.
Cholesterol metabolism and breast cancer.
Stadler SC, Hacker U, Burkhardt R. Stadler SC, et al. Among authors: hacker u. Curr Opin Lipidol. 2016 Apr;27(2):200-1. doi: 10.1097/MOL.0000000000000285. Curr Opin Lipidol. 2016. PMID: 26959708 No abstract available.
[Immunotherapy for gastrointestinal cancer].
Stocker G, Hacker U, Lordick F. Stocker G, et al. Among authors: hacker u. Dtsch Med Wochenschr. 2024 Apr;149(8):432-439. doi: 10.1055/a-2060-2192. Epub 2024 Apr 2. Dtsch Med Wochenschr. 2024. PMID: 38565116 German.
Modifying immune responses to adeno-associated virus vectors by capsid engineering.
Bentler M, Hardet R, Ertelt M, Rudolf D, Kaniowska D, Schneider A, Vondran FWR, Schoeder CT, Delphin M, Lucifora J, Ott M, Hacker UT, Adriouch S, Büning H. Bentler M, et al. Among authors: hacker ut. Mol Ther Methods Clin Dev. 2023 Aug 22;30:576-592. doi: 10.1016/j.omtm.2023.08.015. eCollection 2023 Sep 14. Mol Ther Methods Clin Dev. 2023. PMID: 37693943 Free PMC article.
[What is confirmed in the treatment of colon cancer?].
Lordick F, Hacker U, Hoffmeister A, Bläker H, Gockel I. Lordick F, et al. Among authors: hacker u. Inn Med (Heidelb). 2022 Dec;63(12):1250-1256. doi: 10.1007/s00108-022-01419-4. Epub 2022 Nov 15. Inn Med (Heidelb). 2022. PMID: 36380005 Review. German.
Engineering the AAV capsid to optimize vector-host-interactions.
Büning H, Huber A, Zhang L, Meumann N, Hacker U. Büning H, et al. Among authors: hacker u. Curr Opin Pharmacol. 2015 Oct;24:94-104. doi: 10.1016/j.coph.2015.08.002. Epub 2015 Aug 25. Curr Opin Pharmacol. 2015. PMID: 26302254 Review.
Nivolumab and ipilimumab in recurrent or refractory cancer of unknown primary: a phase II trial.
Pouyiourou M, Kraft BN, Wohlfromm T, Stahl M, Kubuschok B, Löffler H, Hacker UT, Hübner G, Weiss L, Bitzer M, Ernst T, Schütt P, Hielscher T, Delorme S, Kirchner M, Kazdal D, Ball M, Kluck K, Stenzinger A, Bochtler T, Krämer A. Pouyiourou M, et al. Among authors: hacker ut. Nat Commun. 2023 Oct 24;14(1):6761. doi: 10.1038/s41467-023-42400-5. Nat Commun. 2023. PMID: 37875494 Free PMC article. Clinical Trial.
Definitions and treatment of oligometastatic oesophagogastric cancer according to multidisciplinary tumour boards in Europe.
Kroese TE, van Hillegersberg R, Schoppmann S, Deseyne PRAJ, Nafteux P, Obermannova R, Nordsmark M, Pfeiffer P, Hawkins MA, Smyth E, Markar S, Hanna GB, Cheong E, Chaudry A, Elme A, Adenis A, Piessen G, Gani C, Bruns CJ, Moehler M, Liakakos T, Reynolds J, Morganti A, Rosati R, Castoro C, D'Ugo D, Roviello F, Bencivenga M, de Manzoni G, Jeene P, van Sandick JW, Muijs C, Slingerland M, Nieuwenhuijzen G, Wijnhoven B, Beerepoot LV, Kolodziejczyk P, Polkowski WP, Alsina M, Pera M, Kanonnikoff TF, Nilsson M, Guckenberger M, Monig S, Wagner D, Wyrwicz L, Berbee M, Gockel I, Lordick F, Griffiths EA, Verheij M, van Rossum PSN, van Laarhoven HWM; OMEC working group. Kroese TE, et al. Eur J Cancer. 2022 Mar;164:18-29. doi: 10.1016/j.ejca.2021.11.032. Epub 2022 Feb 5. Eur J Cancer. 2022. PMID: 35134666 Free article.
123 results